Voyageur Pharmaceuticals Ltd. (CVE:VM – Get Free Report)’s stock price rose 47.4% during mid-day trading on Saturday . The company traded as high as C$0.14 and last traded at C$0.14. Approximately 1,312,210 shares traded hands during mid-day trading, an increase of 427% from the average daily volume of 249,010 shares. The stock had previously closed at C$0.10.
Voyageur Pharmaceuticals Price Performance
The company has a debt-to-equity ratio of 3.21, a current ratio of 0.17 and a quick ratio of 0.84. The stock’s fifty day moving average is C$0.07 and its 200-day moving average is C$0.06. The stock has a market capitalization of C$19.53 million, a PE ratio of -14.00 and a beta of 0.32.
Voyageur Pharmaceuticals Company Profile
Voyageur Pharmaceuticals Ltd., together with its subsidiaries, engages in the acquiring, exploring, and developing raw materials for pharmaceutical products, primarily in the province of British Columbia, Canada, and the state of Utah. The company develops barium and iodine-based APIs. The company was formerly known as Voyageur Minerals Ltd.
Read More
- Five stocks we like better than Voyageur Pharmaceuticals
- Why Special Dividends Can be a Delightful Surprise for Income Investors
- Driving Forward: Lucid’s Growing Sales and Gravity SUV’s Impact
- Comparing and Trading High PE Ratio Stocks
- Why Amazon’s Next Earnings Could Trigger a Stock Breakout
- How to Evaluate a Stock Before Buying
- With This Kind of Data, The Fed Isn’t Cutting Rates This Year
Receive News & Ratings for Voyageur Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Voyageur Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
